Early Worsening of Quality of Life after Treatment of Stage I Lung Cancer

Dhruvin H Hirpara¹, Biniam Kidane^{2

3

4}

Affiliations

¹ Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
² Section of Thoracic Surgery, Department of Surgery, Rady Faculty of Health Sciences, and.
³ Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; and.
⁴ Research Institute in Oncology and Hematology, Cancer Care Manitoba, Winnipeg, Manitoba, Canada.

Editorial

Dhruvin H Hirpara et al. Ann Am Thorac Soc. 2020 Aug.

. 2020 Aug;17(8):935-936.

doi: 10.1513/AnnalsATS.202005-523ED.

Dhruvin H Hirpara¹, Biniam Kidane^{2

3

4}

¹ Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
² Section of Thoracic Surgery, Department of Surgery, Rady Faculty of Health Sciences, and.
³ Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; and.
⁴ Research Institute in Oncology and Hematology, Cancer Care Manitoba, Winnipeg, Manitoba, Canada.

No abstract available

Comment on

Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non-Small-Cell Lung Cancer.
Nugent SM, Golden SE, Hooker ER, Sullivan DR, Thomas CR Jr, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Moghanaki D, Wisnivesky J, Samson P, Robinson C, Slatore CG. Nugent SM, et al. Ann Am Thorac Soc. 2020 Aug;17(8):988-997. doi: 10.1513/AnnalsATS.202001-029OC. Ann Am Thorac Soc. 2020. PMID: 32433897

1. Chen H, Laba JM, Boldt RG, Goodman CD, Palma DA, Senan S, et al. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies. Int J Radiat Oncol Biol Phys. 2018;101:186–194. - PubMed
1. Nugent SM, Golden SE, Hooker ER, Sullivan DR, Thomas CR, Jr, Deffebach ME, et al. Longitudinal health-related quality of life among individuals considering treatment for stage I non–small-cell lung cancer. Ann Am Thorac Soc. 2020;17:988–997. - PubMed
1. Hirpara DH, Gupta V, Davis LE, Zhao H, Hallet J, Mahar AL, et al. Severe symptoms persist for up to one year after diagnosis of stage I-III lung cancer: an analysis of province-wide patient reported outcomes. Lung Cancer. 2020;142:80–89. - PubMed
1. Steventon A, Grieve R, Bardsley M. An approach to assess generalizability in comparative effectiveness research: a case study of the whole systems demonstrator cluster randomized trial comparing telehealth with usual care for patients with chronic health conditions. Med Decis Making. 2015;35:1023–1036. - PMC - PubMed
1. Chen H, Louie AV, Boldt RG, Rodrigues GB, Palma DA, Senan S. Quality of life after stereotactic ablative radiotherapy for early-stage lung cancer: a systematic review. Clin Lung Cancer. 2016;17:e141–e149. - PubMed